Q1 2025 · 13F-HR
Merck & Co., Inc. (MRK)holdings as filed
Filed 2025-05-14 · accession 0000064978-25-000005
$164.3M
Reported value
12
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 60770K107 | MRNA | MODERNA INC | $65.4M | 39.8% | 2,308,190 | Common | SHARED |
| 71535D106 | PSNL | PERSONALIS INC | $49.3M | 30.0% | 14,044,943 | Common | SHARED |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $21.1M | 12.9% | 772,165 | Common | SHARED |
| 29384C908 | — | ENTRADA THERAPEUTICS INC | $15.7M | 9.57% | 1,739,768 | Common | SHARED |
| 014442107 | ALEC | ALECTOR INC | $4.4M | 2.65% | 3,545,719 | Common | SHARED |
| 29970R204 | EVAXUSD | EVAXION BIOTECH A/S | $2.2M | 1.37% | 1,214,126 | Common | SHARED |
| 869367102 | — | SUTRO BIOPHARMA INC | $1.8M | 1.08% | 2,723,509 | Common | SHARED |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $1.5M | 0.89% | 1,149,345 | Common | SHARED |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $1.3M | 0.77% | 93,414 | Common | SHARED |
| 98422T100 | — | XILIO THERAPEUTICS INC | $1.1M | 0.65% | 1,483,758 | Common | SHARED |
| 14216R101 | CARM | CARISMA THERAPEUTICS INC | $456,704 | 0.28% | 1,473,240 | Common | SHARED |
| 64136E102 | NEUP | NEUPHORIA THERAPEUTICS INC | $57,756 | 0.04% | 10,027 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.